Towards a systems understanding of MHC class I and MHC class II antigen presentation (original) (raw)

• Vyas, J. M., Van der Veen, A. G. & Ploegh, H. L. The known unknowns of antigen processing and presentation. Nature Rev. Immunol. 8, 607–618 (2008).
  Article CAS Google Scholar
• Kurts, C., Robinson, B. W. & Knolle, P. A. Cross-priming in health and disease. Nature Rev. Immunol. 10, 403–414 (2010).
  Article CAS Google Scholar
• Crotzer, V. L. & Blum, J. S. Autophagy and adaptive immunity. Immunology 131, 9–17 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Horst, D., Verweij, M. C., Davison, A. J., Ressing, M. E. & Wiertz, E. J. Viral evasion of T cell immunity: ancient mechanisms offering new applications. Curr. Opin. Immunol. 23, 96–103 (2011).
  Article CAS PubMed Google Scholar
• Hughes, E. A., Hammond, C. & Cresswell, P. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl Acad. Sci. USA 94, 1896–1901 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Koopmann, J. O. et al. Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel. Immunity 13, 117–127 (2000).
  Article CAS PubMed Google Scholar
• Reits, E. A., Vos, J. C., Gromme, M. & Neefjes, J. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404, 774–778 (2000).
  Article CAS PubMed Google Scholar
• Schubert, U. et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404, 770–774 (2000).
  Article CAS PubMed Google Scholar
• Li, M. et al. Widespread RNA and DNA sequence differences in the human transcriptome. Science 333, 53–58 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yewdell, J. W. & Hickman, H. D. New lane in the information highway: alternative reading frame peptides elicit T cells with potent antiretrovirus activity. J. Exp. Med. 204, 2501–2504 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Berglund, P., Finzi, D., Bennink, J. R. & Yewdell, J. W. Viral alteration of cellular translational machinery increases defective ribosomal products. J. Virol. 81, 7220–7229 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Netzer, N. et al. Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature 462, 522–526 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Dolan, B. P. et al. Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance. J. Immunol. 186, 2065–2072 (2011).
  Article CAS PubMed Google Scholar
• Khan, S. et al. Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein. J. Immunol. 167, 4801–4804 (2001).
  Article CAS PubMed Google Scholar
• Vigneron, N. et al. An antigenic peptide produced by peptide splicing in the proteasome. Science 304, 587–590 (2004).
  Article CAS PubMed Google Scholar
• Hanada, K., Yewdell, J. W. & Yang, J. C. Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427, 252–256 (2004).
  Article CAS PubMed Google Scholar
• Dalet, A. et al. An antigenic peptide produced by reverse splicing and double asparagine deamidation. Proc. Natl Acad. Sci. USA 108, e323–e331 (2011). References 9, 11 and 15–17 describe various examples of the generation of non-genetically encoded antigens that can be presented by MHC class I molecules.
  Article CAS PubMed PubMed Central Google Scholar
• Neefjes, J. J. & Ploegh, H. L. Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with β2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur. J. Immunol. 18, 801–810 (1988).
  Article CAS PubMed Google Scholar
• Reits, E. A. et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J. Exp. Med. 203, 1259–1271 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kulkarni, S. et al. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472, 495–498 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Apcher, S. et al. Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc. Natl Acad. Sci. USA 108, 11572–11577 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Gu, W. et al. Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses. Proc. Natl Acad. Sci. USA 106, 8314–8319 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ferrara, T. A., Hodge, J. W. & Gulley, J. L. Combining radiation and immunotherapy for synergistic antitumor therapy. Curr. Opin. Mol. Ther. 11, 37–42 (2009).
  CAS PubMed PubMed Central Google Scholar
• Mester, G., Hoffmann, V. & Stevanovic, S. Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Cell. Mol. Life Sci. 68, 1521–1532 (2011).
  Article CAS PubMed Google Scholar
• Sauer, R. T. & Baker, T. A. AAA+ proteases: ATP-fueled machines of protein destruction. Annu. Rev. Biochem. 80, 587–612 (2011).
  Article CAS PubMed Google Scholar
• Cascio, P., Hilton, C., Kisselev, A. F., Rock, K. L. & Goldberg, A. L. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 20, 2357–2366 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Sijts, E. J. & Kloetzel, P. M. The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell. Mol. Life Sci. 68, 1491–1502 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Toes, R. E. et al. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194, 1–12 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Nitta, T. et al. Thymoproteasome shapes immunocompetent repertoire of CD8+ T cells. Immunity 32, 29–40 (2010).
  Article CAS PubMed Google Scholar
• Seifert, U. et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142, 613–624 (2010). This paper shows how immunological stress induces protein aggregation and pathology. Immunoproteasomes are more active than constitutive proteasomes and prevent aggregation and pathology.
  Article CAS PubMed Google Scholar
• Reits, E. et al. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18, 97–108 (2003).
  Article CAS PubMed Google Scholar
• Wearsch, P. A. & Cresswell, P. The quality control of MHC class I peptide loading. Curr. Opin. Cell Biol. 20, 624–631 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Park, B. et al. Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell 127, 369–382 (2006).
  Article CAS PubMed Google Scholar
• Wearsch, P. A., Peaper, D. R. & Cresswell, P. Essential glycan-dependent interactions optimize MHC class I peptide loading. Proc. Natl Acad. Sci. USA 108, 4950–4955 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Zarling, A. L. et al. Tapasin is a facilitator, not an editor, of class I MHC peptide binding. J. Immunol. 171, 5287–5295 (2003).
  Article CAS PubMed Google Scholar
• Parcej, D. & Tampe, R. ABC proteins in antigen translocation and viral inhibition. Nature Chem. Biol. 6, 572–580 (2010).
  Article CAS Google Scholar
• Blanchard, N. et al. Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J. Immunol. 184, 3033–3042 (2010).
  Article CAS PubMed Google Scholar
• Serwold, T., Gonzalez, F., Kim, J., Jacob, R. & Shastri, N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419, 480–483 (2002).
  Article CAS PubMed Google Scholar
• Saveanu, L. et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nature Immunol. 6, 689–697 (2005).
  Article CAS Google Scholar
• Saric, T. et al. An IFN-γ-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nature Immunol. 3, 1169–1176 (2002).
  Article CAS Google Scholar
• York, I. A. et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8–9 residues. Nature Immunol. 3, 1177–1184 (2002).
  Article CAS Google Scholar
• Roelse, J., Gromme, M., Momburg, F., Hammerling, G. & Neefjes, J. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180, 1591–1597 (1994).
  Article CAS PubMed Google Scholar
• Neijssen, J. et al. Cross-presentation by intercellular peptide transfer through gap junctions. Nature 434, 83–88 (2005).
  Article CAS PubMed Google Scholar
• Pang, B. et al. Direct antigen presentation and gap junction mediated cross-presentation during apoptosis. J. Immunol. 183, 1083–1090 (2009).
  Article CAS PubMed Google Scholar
• Saccheri, F. et al. Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity. Sci. Transl. Med. 2, 44ra57 (2010). This study shows that gap junctions are induced by S . Typhimurium infection and are essential for generating a strong antitumour response with a S . Typhimurium-based antitumour vaccine.
  Article PubMed Google Scholar
• Trowsdale, J. HLA genomics in the third millennium. Curr. Opin. Immunol. 17, 498–504 (2005).
  Article CAS PubMed Google Scholar
• Neisig, A., Melief, C. J. & Neefjes, J. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 160, 171–179 (1998).
  CAS PubMed Google Scholar
• Neisig, A., Wubbolts, R., Zang, X., Melief, C. & Neefjes, J. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156, 3196–3206 (1996).
  CAS PubMed Google Scholar
• Peh, C. A. et al. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 8, 531–542 (1998).
  Article CAS PubMed Google Scholar
• Leslie, A. et al. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J. Virol. 84, 9879–9888 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Malik, P., Klimovitsky, P., Deng, L. W., Boyson, J. E. & Strominger, J. L. Uniquely conformed peptide-containing β2-microglobulin-free heavy chains of HLA-B2705 on the cell surface. J. Immunol. 169, 4379–4387 (2002).
  Article CAS PubMed Google Scholar
• Herberts, C. A. et al. Cutting edge: HLA-B27 acquires many N-terminal dibasic peptides: coupling cytosolic peptide stability to antigen presentation. J. Immunol. 176, 2697–2701 (2006).
  Article CAS PubMed Google Scholar
• Evans, D. M. et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genet. 43, 761–767 (2011).
  Article CAS PubMed Google Scholar
• Princiotta, M. F. et al. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18, 343–354 (2003).
  Article CAS PubMed Google Scholar
• Yewdell, J. W., Reits, E. & Neefjes, J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nature Rev. Immunol. 3, 952–961 (2003).
  Article CAS Google Scholar
• Reits, E. A., Vos, J. C., Gromme, M. & Neefjes, J. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404, 774–778 (2000).
  Article CAS PubMed Google Scholar
• Reits, E. et al. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20, 495–506 (2004).
  Article CAS PubMed Google Scholar
• York, I. A., Bhutani, N., Zendzian, S., Goldberg, A. L. & Rock, K. L. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation. J. Immunol. 177, 1434–1443 (2006).
  Article CAS PubMed Google Scholar
• Kloetzel, P. M. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nature Immunol. 5, 661–669 (2004).
  Article CAS Google Scholar
• Kessler, J. H. et al. Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nature Immunol. 12, 45–53 (2011).
  Article CAS Google Scholar
• Kawahara, M., York, I. A., Hearn, A., Farfan, D. & Rock, K. L. Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo. J. Immunol. 183, 6069–6077 (2009).
  Article CAS PubMed Google Scholar
• Saveanu, L., Carroll, O., Hassainya, Y. & van Endert, P. Complexity, contradictions, and conundrums: studying post-proteasomal proteolysis in HLA class I antigen presentation. Immunol. Rev. 207, 42–59 (2005).
  Article CAS PubMed Google Scholar
• Lev, A. et al. The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. Immunity 28, 787–798 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Lev, A. et al. Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action. Proc. Natl Acad. Sci. USA 107, 6964–6969 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hessa, T. et al. Protein targeting and degradation are coupled for elimination of mislocalized proteins. Nature 475, 394–397 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tenzer, S. et al. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell. Mol. Life Sci. 62, 1025–1037 (2005).
  Article CAS PubMed Google Scholar
• Lundegaard, C., Lund, O., Buus, S. & Nielsen, M. Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 130, 309–318 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Martayan, A. et al. Class I HLA folding and antigen presentation in β2-microglobulin-defective Daudi cells. J. Immunol. 182, 3609–3617 (2009).
  Article CAS PubMed Google Scholar
• Gromme, M. et al. Recycling MHC class I molecules and endosomal peptide loading. Proc. Natl Acad. Sci. USA 96, 10326–10331 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Rocca, A. et al. Localization of the conformational alteration of MHC molecules induced by the association of mouse class I heavy chain with a xenogeneic β2-microglobulin. Mol. Immunol. 29, 481–487 (1992).
  Article CAS PubMed Google Scholar
• Neefjes, J. J., Smit, L., Gehrmann, M. & Ploegh, H. L. The fate of the three subunits of major histocompatibility complex class I molecules. Eur. J. Immunol. 22, 1609–1614 (1992).
  Article CAS PubMed Google Scholar
• Boname, J. M. et al. Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains. Traffic 11, 210–220 (2010).
  Article CAS PubMed Google Scholar
• Bartee, E., Mansouri, M., Hovey Nerenberg, B. T., Gouveia, K. & Fruh, K. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J. Virol. 78, 1109–1120 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Howe, C. et al. Calreticulin-dependent recycling in the early secretory pathway mediates optimal peptide loading of MHC class I molecules. EMBO J. 28, 3730–3744 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Fernando, M. M. et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet. 4, e1000024 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Anders, A. K. et al. HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nature Immunol. 12, 54–61 (2011).
  Article CAS Google Scholar
• Denzin, L. K., Fallas, J. L., Prendes, M. & Yi, W. Right place, right time, right peptide: DO keeps DM focused. Immunol. Rev. 207, 279–292 (2005).
  Article CAS PubMed Google Scholar
• Romieu-Mourez, R., Francois, M., Boivin, M. N., Stagg, J. & Galipeau, J. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-γ, TGF-β, and cell density. J. Immunol. 179, 1549–1558 (2007).
  Article CAS PubMed Google Scholar
• Geppert, T. D. & Lipsky, P. E. Antigen presentation by interferon-γ-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J. Immunol. 135, 3750–3762 (1985).
  CAS PubMed Google Scholar
• Bland, P. MHC class II expression by the gut epithelium. Immunol. Today 9, 174–178 (1988).
  Article CAS PubMed Google Scholar
• Koretz, K., Leman, J., Brandt, I. & Moller, P. Metachromasia of 3-amino-9-ethylcarbazole (AEC) and its prevention in immunoperoxidase techniques. Histochemistry 86, 471–478 (1987).
  Article CAS PubMed Google Scholar
• Mulder, D. J. et al. Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis. Am. J. Pathol. 178, 744–753 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Schonefuss, A. et al. Upregulation of cathepsin S in psoriatic keratinocytes. Exp. Dermatol. 19, e80–e88 (2010).
  Article PubMed Google Scholar
• Tjernlund, U. M., Scheynius, A., Kabelitz, D. & Klareskog, L. Anti-Ia-reactive cells in mycosis fungoides: a study of skin biopsies, single epidermal cells and circulating T lymphocytes. Acta Derm. Venereol. 61, 291–301 (1981).
  CAS PubMed Google Scholar
• Choi, N. M., Majumder, P. & Boss, J. M. Regulation of major histocompatibility complex class II genes. Curr. Opin. Immunol. 23, 81–87 (2011).
  Article CAS PubMed Google Scholar
• Muhlethaler-Mottet, A., Otten, L. A., Steimle, V. & Mach, B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16, 2851–2860 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Reith, W., LeibundGut-Landmann, S. & Waldburger, J. M. Regulation of MHC class II gene expression by the class II transactivator. Nature Rev. Immunol. 5, 793–806 (2005).
  Article CAS Google Scholar
• Smith, M. A. et al. Positive regulatory domain I (PRDM1) and IRF8/Pu.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation. J. Biol. Chem. 286, 7893–7904 (2011). A study of the transcriptional regulation of MHC class II expression in immature and mature DCs.
  Article CAS PubMed PubMed Central Google Scholar
• Sisk, T. J., Nickerson, K., Kwok, R. P. & Chang, C. H. Phosphorylation of class II transactivator regulates its interaction ability and transactivation function. Int. Immunol. 15, 1195–1205 (2003).
  Article CAS PubMed Google Scholar
• Greer, S. F. et al. Serine residues 286, 288, and 293 within the CIITA: a mechanism for down-regulating CIITA activity through phosphorylation. J. Immunol. 173, 376–383 (2004).
  Article CAS PubMed Google Scholar
• Bhat, K. P., Truax, A. D. & Greer, S. F. Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression. J. Biol. Chem. 285, 25893–25903 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Greer, S. F., Zika, E., Conti, B., Zhu, X. S. & Ting, J. P. Enhancement of CIITA transcriptional function by ubiquitin. Nature Immunol. 4, 1074–1082 (2003).
  Article CAS Google Scholar
• Paul, P. et al. A genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell 145, 268–283 (2011). A genome-wide siRNA screen for factors that control expression and peptide loading of MHC class II molecules. Many unknown factors are identified and additional screens are presented to reveal new pathways controlling MHC class II expression and transport in immature DCs.
  Article CAS PubMed Google Scholar
• Busch, R., Doebele, R. C., Patil, N. S., Pashine, A. & Mellins, E. D. Accessory molecules for MHC class II peptide loading. Curr. Opin. Immunol. 12, 99–106 (2000).
  Article CAS PubMed Google Scholar
• Bertolino, P. & Rabourdin-Combe, C. The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells. Crit. Rev. Immunol. 16, 359–379 (1996).
  CAS PubMed Google Scholar
• Landsverk, O. J., Bakke, O. & Gregers, T. F. MHC II and the endocytic pathway: regulation by invariant chain. Scand. J. Immunol. 70, 184–193 (2009).
  Article CAS PubMed Google Scholar
• Bodmer, H., Viville, S., Benoist, C. & Mathis, D. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 263, 1284–1286 (1994).
  Article CAS PubMed Google Scholar
• Viville, S. et al. Mice lacking the MHC class II-associated invariant chain. Cell 72, 635–648 (1993).
  Article CAS PubMed Google Scholar
• Bikoff, E. K. et al. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177, 1699–1712 (1993).
  Article CAS PubMed Google Scholar
• Tewari, M. K., Sinnathamby, G., Rajagopal, D. & Eisenlohr, L. C. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nature Immunol. 6, 287–294 (2005).
  Article CAS Google Scholar
• Hofmann, M. W. et al. The leucine-based sorting motifs in the cytoplasmic domain of the invariant chain are recognized by the clathrin adaptors AP1 and AP2 and their medium chains. J. Biol. Chem. 274, 36153–36158 (1999).
  Article CAS PubMed Google Scholar
• Dugast, M., Toussaint, H., Dousset, C. & Benaroch, P. AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes. J. Biol. Chem. 280, 19656–19664 (2005).
  Article CAS PubMed Google Scholar
• McCormick, P. J., Martina, J. A. & Bonifacino, J. S. Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments. Proc. Natl Acad. Sci. USA 102, 7910–7915 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Santambrogio, L. et al. Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells. Nature Immunol. 6, 1020–1028 (2005).
  Article CAS Google Scholar
• Peters, P. J., Neefjes, J. J., Oorschot, V., Ploegh, H. L. & Geuze, H. J. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349, 669–676 (1991).
  Article CAS PubMed Google Scholar
• Sanderson, F. et al. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266, 1566–1569 (1994).
  Article CAS PubMed Google Scholar
• Kropshofer, H. et al. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 15, 6144–6154 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Engering, A. & Pieters, J. Association of distinct tetraspanins with MHC class II molecules at different subcellular locations in human immature dendritic cells. Int. Immunol. 13, 127–134 (2001).
  Article CAS PubMed Google Scholar
• Hsing, L. C. & Rudensky, A. Y. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207, 229–241 (2005).
  Article CAS PubMed Google Scholar
• Hartman, I. Z. et al. A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes. Nature Med. 16, 1333–1340 (2010).
  Article CAS PubMed Google Scholar
• Raiborg, C. & Stenmark, H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458, 445–452 (2009).
  Article CAS PubMed Google Scholar
• Zwart, W. et al. Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape. Immunity 22, 221–233 (2005).
  Article CAS PubMed Google Scholar
• ten Broeke, T., van Niel, G., Wauben, M. H., Wubbolts, R. & Stoorvogel, W. Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions. Traffic 12, 1025–1036 (2011).
  Article CAS PubMed Google Scholar
• Neefjes, J. J., Stollorz, V., Peters, P. J., Geuze, H. J. & Ploegh, H. L. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61, 171–183 (1990).
  Article CAS PubMed Google Scholar
• Nordeng, T. W. et al. The cytoplasmic tail of invariant chain regulates endosome fusion and morphology. Mol. Biol. Cell 13, 1846–1856 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Landsverk, O. J., Barois, N., Gregers, T. F. & Bakke, O. Invariant chain increases the half-life of MHC II by delaying endosomal maturation. Immunol. Cell Biol. 89, 619–629 (2011).
  Article CAS PubMed Google Scholar
• Strong, B. S. & Unanue, E. R. Presentation of type B peptide–MHC complexes from hen egg white lysozyme by TLR ligands and type I IFNs independent of H2-DM regulation. J. Immunol. 187, 2193–2201 (2011).
  Article CAS PubMed Google Scholar
• Trombetta, E. S., Ebersold, M., Garrett, W., Pypaert, M. & Mellman, I. Activation of lysosomal function during dendritic cell maturation. Science 299, 1400–1403 (2003).
  Article CAS PubMed Google Scholar
• Rocha, N. et al. Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7–RILP–p150Glued and late endosome positioning. J. Cell Biol. 185, 1209–1225 (2009). This study reveals the complex effects of motor regulation on the MIIC and other late endosomes. Cholesterol in late endosomes and/or the MIIC controls interactions with the ER protein VAPA, which removes the dynein motor from its receptor RILP, resulting in vesicle relocation.
  Article CAS PubMed PubMed Central Google Scholar
• Kuipers, H. F. et al. Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains. Hum. Immunol. 66, 653–665 (2005).
  Article CAS PubMed Google Scholar
• Cella, M., Engering, A., Pinet, V., Pieters, J. & Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782–787 (1997).
  CAS PubMed Google Scholar
• Pierre, P. et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787–792 (1997).
  Article CAS PubMed Google Scholar
• Boes, M. et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418, 983–988 (2002).
  Article CAS PubMed Google Scholar
• Wubbolts, R. et al. Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface. J. Cell Biol. 135, 611–622 (1996).
  Article CAS PubMed Google Scholar
• Kleijmeer, M. et al. Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J. Cell Biol. 155, 53–63 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Vascotto, F. et al. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation. J. Cell Biol. 176, 1007–1019 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Saftig, P. & Klumperman, J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nature Rev. Mol. Cell Biol. 10, 623–635 (2009).
  Article CAS Google Scholar
• de Gassart, A. et al. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc. Natl Acad. Sci. USA 105, 3491–3496 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Shin, J. S. et al. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444, 115–118 (2006).
  Article CAS PubMed Google Scholar
• Thibodeau, J. et al. Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur. J. Immunol. 38, 1225–1230 (2008). This study explains the effects of IL-10 on MHC class II expression in human monocytes. IL-10 controls MARCH1 expression, which in turn controls the half-life of MHC class II on the cell surface.
  Article CAS PubMed PubMed Central Google Scholar
• Koppelman, B., Neefjes, J. J., de Vries, J. E. & Waal Malefyt, R. Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7, 861–871 (1997).
  Article CAS PubMed Google Scholar
• Tze, L. E. et al. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J. Exp. Med. 208, 149–165 (2011). This study shows how CD83 inhibits MHC class II ubiquitylation by MARCH1.
  Article CAS PubMed PubMed Central Google Scholar
• McGehee, A. M. et al. Ubiquitin-dependent control of class II MHC localization is dispensable for antigen presentation and antibody production. PLoS ONE 6, e18817 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Walseng, E. et al. Ubiquitination regulates MHC class II–peptide complex retention and degradation in dendritic cells. Proc. Natl Acad. Sci. USA 107, 20465–20470 (2010). This article shows how ubiquitylation regulates the degradation of internalized MHC class II molecules but not the endocytosis of MHC class II.
  Article CAS PubMed PubMed Central Google Scholar
• Al Daccak, R., Mooney, N. & Charron, D. MHC class II signaling in antigen-presenting cells. Curr. Opin. Immunol. 16, 108–113 (2004).
  Article CAS PubMed Google Scholar
• Drenou, B. et al. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. J. Immunol. 163, 4115–4124 (1999).
  CAS PubMed Google Scholar
• Hemon, P. et al. MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis. J. Immunol. 186, 5173–5183 (2011).
  Article CAS PubMed Google Scholar
• Liu, X. et al. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nature Immunol. 12, 416–424 (2011). This comprehensive study reveals crosstalk between TLRs, MHC class II and CD40. A full mechanism is presented to describe how MHC class II molecules are involved in outside-in signalling.
  Article CAS Google Scholar
• Lang, P. et al. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-α/β dimers. Science 291, 1537–1540 (2001).
  Article CAS PubMed Google Scholar
• Bonnefoy, J. Y. et al. The low-affinity receptor for IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens. J. Exp. Med. 167, 57–72 (1988).
  Article CAS PubMed Google Scholar
• Bradbury, L. E., Kansas, G. S., Levy, S., Evans, R. L. & Tedder, T. F. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149, 2841–2850 (1992).
  CAS PubMed Google Scholar
• van der Burg, S. H. & Melief, C. J. Therapeutic vaccination against human papilloma virus induced malignancies. Curr. Opin. Immunol. 23, 252–257 (2011).
  Article CAS PubMed Google Scholar
• Mitea, C. et al. A universal approach to eliminate antigenic properties of α-gliadin peptides in celiac disease. PLoS ONE 5, e15637 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Baugh, M. et al. Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity. J. Autoimmun. 36, 201–209 (2011).
  Article CAS PubMed Google Scholar
• Fallang, L. E. et al. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nature Immunol. 10, 1096–1101 (2009).
  Article CAS Google Scholar
• Chow, K. M. et al. Studies on the subsite specificity of rat nardilysin (N-arginine dibasic convertase). J. Biol. Chem. 275, 19545–19551 (2000).
  Article CAS PubMed Google Scholar
• Chow, K. M. et al. Nardilysin cleaves peptides at monobasic sites. Biochemistry 42, 2239–2244 (2003).
  Article CAS PubMed Google Scholar
• York, I. A. et al. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity 18, 429–440 (2003).
  Article CAS PubMed Google Scholar
• Kim, S. I., Pabon, A., Swanson, T. A. & Glucksman, M. J. Regulation of cell-surface major histocompatibility complex class I expression by the endopeptidase EC3.4.24.15 (thimet oligopeptidase). Biochem. J. 375, 111–120 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Rock, K. L., York, I. A., Saric, T. & Goldberg, A. L. Protein degradation and the generation of MHC class I-presented peptides. Adv. Immunol. 80, 1–70 (2002).
  Article CAS PubMed Google Scholar
• Bhutani, N., Venkatraman, P. & Goldberg, A. L. Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation. EMBO J. 26, 1385–1396 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Stoltze, L. et al. Two new proteases in the MHC class I processing pathway. Nature Immunol. 1, 413–418 (2000).
  Article CAS Google Scholar
• Parmentier, N. et al. Production of an antigenic peptide by insulin-degrading enzyme. Nature Immunol. 11, 449–454 (2010).
  Article CAS Google Scholar
• Shen, X. Z., Lukacher, A. E., Billet, S., Williams, I. R. & Bernstein, K. E. Expression of angiotensin-converting enzyme changes major histocompatibility complex class I peptide presentation by modifying C termini of peptide precursors. J. Biol. Chem. 283, 9957–9965 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chang, S. C., Momburg, F., Bhutani, N. & Goldberg, A. L. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a “molecular ruler” mechanism. Proc. Natl Acad. Sci. USA 102, 17107–17112 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Hammer, G. E., Gonzalez, F., James, E., Nolla, H. & Shastri, N. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nature Immunol. 8, 101–108 (2007).
  Article CAS Google Scholar
• Nguyen, T. T. et al. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nature Struct. Mol. Biol. 18, 604–613 (2011). References 39 and 155–157 show how ERAAP acts as a molecular ruler for MHC class I peptides and skews the peptide repertoire.
  Article CAS Google Scholar
• Kreisel, D. et al. Cutting edge: MHC class II expression by pulmonary nonhematopoietic cells plays a critical role in controlling local inflammatory responses. J. Immunol. 185, 3809–3813 (2010).
  Article CAS PubMed Google Scholar